Publicaciones en las que colabora con Angel Luis Guerrero Peral (3)

2024

  1. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

2010

  1. Zonisamida en el tratamiento preventivo de la migraña refractaria

    Revista de Neurologia, Vol. 50, Núm. 3, pp. 129-132